Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative

We tested for antigen recognition and T cell receptor (TCR)-ligand binding 12 peptide derivative variants on seven H-2Kd-restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252-260 (SYIPSAEKI). The de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 1997-02, Vol.185 (4), p.629-640
Hauptverfasser: Kessler, B M, Bassanini, P, Cerottini, J C, Luescher, I F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 640
container_issue 4
container_start_page 629
container_title The Journal of experimental medicine
container_volume 185
creator Kessler, B M
Bassanini, P
Cerottini, J C
Luescher, I F
description We tested for antigen recognition and T cell receptor (TCR)-ligand binding 12 peptide derivative variants on seven H-2Kd-restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252-260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd-peptide derivative complexes allowed direct assessment of TCR-ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR-ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was five-tenfold less efficient than TCR-ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR-ligand binding, and (d) one partial TCR agonist, which activated only Fas (C1)95), but not perforin/granzyme-mediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR-ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR-ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function.
doi_str_mv 10.1084/jem.185.4.629
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2196149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78824921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2299-47171c9287324f4fcd7b3cf5317a426f73d82de90344266d1f4a83b7e849f77c3</originalsourceid><addsrcrecordid>eNpVUcGOFCEUJEazjqtHjyacvPUINN00FxOzWV3jJl7WM6Hh0cumG1pgJs7n-WfS7mSjCQnwXr2qlyqE3lKyp2TgHx5g2dOh2_N9z-QztKMdJ43s2uE52hHCWEMJES_Rq5wfCKGcd_0FupCk5ZSzHfp97RyYknF0GFZf4gp4idY7b3TxMeB67rCBecYJDKwlpmb2kw4Wjz5YHya8vXUofoKwYeIU_N_J8YQzHGvxpmHfbJMgl-RNAYvNqcQSf3lTqefTst7HWgFs5hgg47yC2fSxiwlrXLtVFLQp_gh4rSt4C9hC8ke9lV6jF07PGd6c70v04_P13dVNc_v9y9erT7eNYUzKhgsqqJFsEC3jjjtjxdga17VUaM56J1o7MAubMfXbW-q4HtpRwMClE8K0l-jjI-96GBewBkJJelZr8otOJxW1V_93gr9XUzwqRmVPuawE788EKf48VDfU4vPmrA4QD1mJYWBcMlqBzSPQpJhzAvckQonaMlc1c1UzV1zVzCv-3b-bPaHPIbd_AGKXras</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78824921</pqid></control><display><type>article</type><title>Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kessler, B M ; Bassanini, P ; Cerottini, J C ; Luescher, I F</creator><creatorcontrib>Kessler, B M ; Bassanini, P ; Cerottini, J C ; Luescher, I F</creatorcontrib><description>We tested for antigen recognition and T cell receptor (TCR)-ligand binding 12 peptide derivative variants on seven H-2Kd-restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252-260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd-peptide derivative complexes allowed direct assessment of TCR-ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR-ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was five-tenfold less efficient than TCR-ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR-ligand binding, and (d) one partial TCR agonist, which activated only Fas (C1)95), but not perforin/granzyme-mediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR-ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR-ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.185.4.629</identifier><identifier>PMID: 9034142</identifier><language>eng</language><publisher>United States: The Rockefeller University Press</publisher><subject>Affinity Labels ; AIDS/HIV ; Amino Acid Sequence ; CD8-Positive T-Lymphocytes ; Cell Line ; Clone Cells ; fas Receptor - immunology ; H-2 Antigens - immunology ; Membrane Glycoproteins - immunology ; Molecular Sequence Data ; Peptides - chemistry ; Peptides - immunology ; Perforin ; Pore Forming Cytotoxic Proteins ; Receptors, Antigen, T-Cell - antagonists &amp; inhibitors ; Receptors, Antigen, T-Cell - immunology ; Receptors, Antigen, T-Cell - metabolism ; T-Lymphocytes, Cytotoxic - immunology</subject><ispartof>The Journal of experimental medicine, 1997-02, Vol.185 (4), p.629-640</ispartof><rights>1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2299-47171c9287324f4fcd7b3cf5317a426f73d82de90344266d1f4a83b7e849f77c3</citedby><cites>FETCH-LOGICAL-c2299-47171c9287324f4fcd7b3cf5317a426f73d82de90344266d1f4a83b7e849f77c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9034142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kessler, B M</creatorcontrib><creatorcontrib>Bassanini, P</creatorcontrib><creatorcontrib>Cerottini, J C</creatorcontrib><creatorcontrib>Luescher, I F</creatorcontrib><title>Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>We tested for antigen recognition and T cell receptor (TCR)-ligand binding 12 peptide derivative variants on seven H-2Kd-restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252-260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd-peptide derivative complexes allowed direct assessment of TCR-ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR-ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was five-tenfold less efficient than TCR-ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR-ligand binding, and (d) one partial TCR agonist, which activated only Fas (C1)95), but not perforin/granzyme-mediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR-ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR-ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function.</description><subject>Affinity Labels</subject><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>CD8-Positive T-Lymphocytes</subject><subject>Cell Line</subject><subject>Clone Cells</subject><subject>fas Receptor - immunology</subject><subject>H-2 Antigens - immunology</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Molecular Sequence Data</subject><subject>Peptides - chemistry</subject><subject>Peptides - immunology</subject><subject>Perforin</subject><subject>Pore Forming Cytotoxic Proteins</subject><subject>Receptors, Antigen, T-Cell - antagonists &amp; inhibitors</subject><subject>Receptors, Antigen, T-Cell - immunology</subject><subject>Receptors, Antigen, T-Cell - metabolism</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUcGOFCEUJEazjqtHjyacvPUINN00FxOzWV3jJl7WM6Hh0cumG1pgJs7n-WfS7mSjCQnwXr2qlyqE3lKyp2TgHx5g2dOh2_N9z-QztKMdJ43s2uE52hHCWEMJES_Rq5wfCKGcd_0FupCk5ZSzHfp97RyYknF0GFZf4gp4idY7b3TxMeB67rCBecYJDKwlpmb2kw4Wjz5YHya8vXUofoKwYeIU_N_J8YQzHGvxpmHfbJMgl-RNAYvNqcQSf3lTqefTst7HWgFs5hgg47yC2fSxiwlrXLtVFLQp_gh4rSt4C9hC8ke9lV6jF07PGd6c70v04_P13dVNc_v9y9erT7eNYUzKhgsqqJFsEC3jjjtjxdga17VUaM56J1o7MAubMfXbW-q4HtpRwMClE8K0l-jjI-96GBewBkJJelZr8otOJxW1V_93gr9XUzwqRmVPuawE788EKf48VDfU4vPmrA4QD1mJYWBcMlqBzSPQpJhzAvckQonaMlc1c1UzV1zVzCv-3b-bPaHPIbd_AGKXras</recordid><startdate>19970217</startdate><enddate>19970217</enddate><creator>Kessler, B M</creator><creator>Bassanini, P</creator><creator>Cerottini, J C</creator><creator>Luescher, I F</creator><general>The Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19970217</creationdate><title>Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative</title><author>Kessler, B M ; Bassanini, P ; Cerottini, J C ; Luescher, I F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2299-47171c9287324f4fcd7b3cf5317a426f73d82de90344266d1f4a83b7e849f77c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Affinity Labels</topic><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>CD8-Positive T-Lymphocytes</topic><topic>Cell Line</topic><topic>Clone Cells</topic><topic>fas Receptor - immunology</topic><topic>H-2 Antigens - immunology</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Molecular Sequence Data</topic><topic>Peptides - chemistry</topic><topic>Peptides - immunology</topic><topic>Perforin</topic><topic>Pore Forming Cytotoxic Proteins</topic><topic>Receptors, Antigen, T-Cell - antagonists &amp; inhibitors</topic><topic>Receptors, Antigen, T-Cell - immunology</topic><topic>Receptors, Antigen, T-Cell - metabolism</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kessler, B M</creatorcontrib><creatorcontrib>Bassanini, P</creatorcontrib><creatorcontrib>Cerottini, J C</creatorcontrib><creatorcontrib>Luescher, I F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kessler, B M</au><au>Bassanini, P</au><au>Cerottini, J C</au><au>Luescher, I F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>1997-02-17</date><risdate>1997</risdate><volume>185</volume><issue>4</issue><spage>629</spage><epage>640</epage><pages>629-640</pages><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>We tested for antigen recognition and T cell receptor (TCR)-ligand binding 12 peptide derivative variants on seven H-2Kd-restricted cytotoxic T lymphocytes (CTL) clones specific for a bifunctional photoreactive derivative of the Plasmodium berghei circumsporozoite peptide 252-260 (SYIPSAEKI). The derivative contained iodo-4-azidosalicylic acid in place of PbCS S-252 and 4-azidobenzoic acid on PbCS K-259. Selective photoactivation of the N-terminal photoreactive group allowed crosslinking to Kd molecules and photoactivation of the orthogonal group to TCR. TCR photoaffinity labeling with covalent Kd-peptide derivative complexes allowed direct assessment of TCR-ligand binding on living CTL. In most cases (over 80%) cytotoxicity (chromium release) and TCR-ligand binding differed by less than fivefold. The exceptions included (a) partial TCR agonists (8 cases), for which antigen recognition was five-tenfold less efficient than TCR-ligand binding, (b) TCR antagonists (2 cases), which were not recognized and capable of inhibiting recognition of the wild-type conjugate, (c) heteroclitic agonists (2 cases), for which antigen recognition was more efficient than TCR-ligand binding, and (d) one partial TCR agonist, which activated only Fas (C1)95), but not perforin/granzyme-mediated cytotoxicity. There was no correlation between these divergences and the avidity of TCR-ligand binding, indicating that other factors than binding avidity determine the nature of the CTL response. An unexpected and novel finding was that CD8-dependent clones clearly incline more to TCR antagonism than CD8-independent ones. As there was no correlation between CD8 dependence and the avidity of TCR-ligand binding, the possibility is suggested that CD8 plays a critical role in aberrant CTL function.</abstract><cop>United States</cop><pub>The Rockefeller University Press</pub><pmid>9034142</pmid><doi>10.1084/jem.185.4.629</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 1997-02, Vol.185 (4), p.629-640
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2196149
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Affinity Labels
AIDS/HIV
Amino Acid Sequence
CD8-Positive T-Lymphocytes
Cell Line
Clone Cells
fas Receptor - immunology
H-2 Antigens - immunology
Membrane Glycoproteins - immunology
Molecular Sequence Data
Peptides - chemistry
Peptides - immunology
Perforin
Pore Forming Cytotoxic Proteins
Receptors, Antigen, T-Cell - antagonists & inhibitors
Receptors, Antigen, T-Cell - immunology
Receptors, Antigen, T-Cell - metabolism
T-Lymphocytes, Cytotoxic - immunology
title Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20epitope%20modification%20on%20T%20cell%20receptor-ligand%20binding%20and%20antigen%20recognition%20by%20seven%20H-2Kd-restricted%20cytotoxic%20T%20lymphocyte%20clones%20specific%20for%20a%20photoreactive%20peptide%20derivative&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Kessler,%20B%20M&rft.date=1997-02-17&rft.volume=185&rft.issue=4&rft.spage=629&rft.epage=640&rft.pages=629-640&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.185.4.629&rft_dat=%3Cproquest_pubme%3E78824921%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78824921&rft_id=info:pmid/9034142&rfr_iscdi=true